Edition:
United Kingdom

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
8:59pm GMT
Change (% chg)

$-0.07 (-6.09%)
Prev Close
$1.15
Open
$1.16
Day's High
$1.16
Day's Low
$1.08
Volume
17,116
Avg. Vol
18,092
52-wk High
$2.25
52-wk Low
$1.08

Chart for

About

Cyclacel Pharmaceuticals, Inc. operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor... (more)

Overall

Beta: 3.74
Market Cap(Mil.): $22.80
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

  CYCC.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -2.42 -- --
ROI: -75.99 -0.29 14.22
ROE: -78.45 0.40 15.99

Earnings vs. Estimates